Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia
1 other identifier
interventional
98
1 country
1
Brief Summary
This randomized controlled trials study aims, first, to determine the effectiveness of a nurse-led PNE program designed by a multidisciplinary team, compared with an active control group on pain intensity, fibromyalgia (FM) severity, pain catastrophizing, and cognitive performance in patients with FM. Second, to determine the mediator role of pain catastrophizing in the effects of PNE on outcomes of interest. Third, to explore PNE-induced changes to the brain circuitry using QEEG in patients with FM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 6, 2023
CompletedFirst Submitted
Initial submission to the registry
October 18, 2023
CompletedFirst Posted
Study publicly available on registry
October 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
ExpectedNovember 20, 2024
November 1, 2024
2.5 years
October 18, 2023
November 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
the Brief Pain Inventory-Short Form (BPI-SF)
The BPI-SF evaluates pain in different contexts: worst pain, least pain, average pain, and current pain, rated on a 0-10 scale.
baseline; T1 = immediately after PNE; T2 = 3th month after intervention.
the Fibromyalgia Impact Questionnaire Revised (FIQR)
The FIQR includes 21 questions involving 3 domains: physical function, overall effect of fibromyalgia, and fibromyalgia symptoms (pain, fatigue, unrefreshing sleep, stiffness, anxiety, depression, tenderness to touch, memory, balance, and environmental sensitivity).
baseline; T1 = immediately after PNE; T2 = 3th month after intervention.
Secondary Outcomes (2)
Pain Catastrophizing Scale(PCS)
baseline; T1 = immediately after PNE; T2 = 3th month after intervention.
Psychomotor Vigilance Test (PVT)
baseline; T1 = immediately after PNE; T2 = 3th month after intervention.
Other Outcomes (1)
Quantitative electroencephalography
baseline; T1 = immediately after PNE; T2 = 3th month after intervention.
Study Arms (2)
Self-Management Education
ACTIVE COMPARATORParticipants in the control group will receive an SME via weekly video calls over 6 weeks.
Pain Neuroscience Education
EXPERIMENTALParticipants in the experimental group will receive a 6-week PNE program.
Interventions
A self-management of the FM handbook will be provided. SME will be delivered via weekly video calls over a 6-week period. The video call lasting for 15 minutes, will consist of reviewing the weekly self-management content (5 min), questioning and answering related to the content of the self-management handbook (5 min), and a debriefing session (5 min).
Participants in the experimental group will receive a 6-week PNE program. The PNE program that is designed to explain pain to the participants will be implemented via 6 individual face-to-face sessions, each lasting for 45 minutes over a 6-week period. Printed take-home materials will be provided to the participants to enhance learning. The goal of PNE is to increase participants' knowledge about pain to help them reconceptualize their beliefs about pain and decrease perceived threats of pain. The content will be composed according to the second edition of the book, "Explain Pain" by Butler and Mosley (2013) as well as etiologies of fibromyalgia. Accordingly, the PI has developed the preliminary PNE content.
Eligibility Criteria
You may qualify if:
- Participants must read and understand Chinese language.
- According to the 2016 ACR diagnostic criteria, participants' PDS scores more than or equal to 13 points
You may not qualify if:
- Subjects who have medical history of traumatic brain injury or neurological disorder.
- Subjects who have present psychopathologic disorder.
- Subjects who are cancer.
- Subjects who are pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bio-Behavior Research Laboratory
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Pei-Shan Tsai, PhD
Taipei Medical University, Taiwan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- We will employ a triple masking protocol in which the PNE educator, participants, and data collectors will all be blinded to group assignments. In addition, we will mask the group assignment to the data analyzer.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 18, 2023
First Posted
October 24, 2023
Study Start
September 6, 2023
Primary Completion
February 28, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
November 20, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share